PMID: 9529023Apr 7, 1998Paper

Breast carcinoma survival analysis for African American and white women in an equal-access health care system

Cancer
B E WojcikS A Optenberg

Abstract

This retrospective review of breast carcinoma cases in the Department of Defense (DoD) Central Tumor Registry evaluated differences in survival patterns between African American and white women treated in U.S. military health care facilities. The study examined the effects of age, stage of cancer, tumor size, grade, lymph node involvement, waiting time between diagnosis and first treatment, marital status, military dependent status, alcohol usage, tobacco usage, and family history of cancer. Researchers reviewed the tumor registry records of 6577 women (5879 whites and 698 African Americans) diagnosed with breast carcinoma. The patients, ages 19-97 years, were diagnosed between 1975 and 1994. A hazard ratio (relative risk of mortality) model compared African American and white patients, adjusting for various combinations of covariates; impact of independent variables on the risk of death; prognostic factors significantly associated with survival; disease free and overall survival times; effects of ethnicity, stage, and age on survival; and trends in stage at diagnosis. A P value (2-sided) of less than 0.05 was considered statistically significant. After adjustment for age, the risk of death was 1.45 (95% confidence interval [CI...Continue Reading

References

Oct 15, 1992·American Journal of Epidemiology·J L BernsteinT R Holford
Jul 1, 1991·American Journal of Epidemiology·J R PalmerS Shapiro
Feb 1, 1990·American Journal of Epidemiology·S Y ChuM L Gwinn
Jan 1, 1989·American Journal of Public Health·J L Stanford, R S Greenberg
Oct 15, 1985·Cancer·D E Anderson, M D Badzioch
Aug 5, 1988·JAMA : the Journal of the American Medical Association·M P LongneckerT C Chalmers
Aug 1, 1988·American Journal of Epidemiology·P L Horn, W D Thompson
Jan 1, 1986·Journal of Chronic Diseases·R P BainJ P Whitaker
Feb 1, 1987·American Journal of Epidemiology·J L StanfordR N Hoover
Jan 1, 1980·CA: a Cancer Journal for Clinicians·L GarfinkelE Silverberg
Jan 1, 1982·Journal of Chronic Diseases·H H DayalC Chiu
Nov 22, 1995·JAMA : the Journal of the American Medical Association·S A OptenbergB Kramer
May 4, 1994·Journal of the National Cancer Institute·R M ElledgeC K Osborne
Jan 1, 1993·Epidemiologic Reviews·J R Palmer, L Rosenberg
Jan 1, 1993·Epidemiologic Reviews·M D Gammon, E M John
Jan 1, 1993·Epidemiologic Reviews·J L Kelsey, P L Horn-Ross
Jul 3, 1996·JAMA : the Journal of the American Medical Association·K KerlikowskeV Ernster
May 1, 1997·American Journal of Public Health·F Chevarley, E White

❮ Previous
Next ❯

Citations

Nov 1, 2007·Women's Health·Leah S Karliner, Karla Kerlikowske
Nov 2, 2006·American Journal of Public Health·Paula M LantzSteven J Katz
Jun 12, 2009·Journal of Women's Health·Linda Vona-Davis, David P Rose
Feb 2, 2011·Journal of Women's Health·Gertraud MaskarinecBrian F Issell
Jan 5, 2002·American Journal of Public Health·Sharon Stein MerkinNeil Powe
Mar 23, 2007·Breast Cancer Research and Treatment·Isabelle SoerjomataramJan Willem W Coebergh
Oct 7, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Emily Rose SmithJames R Hebert
May 14, 2011·American Journal of Public Health·Jenine K HarrisAimee I James
Feb 19, 2013·Breast Cancer Research and Treatment·Nataliya G BatinaOguzhan Alagoz
Feb 26, 2015·Journal of Surgical Oncology·Julie A RizzoCletus A Arciero
May 4, 2010·International Journal of Radiation Oncology, Biology, Physics·Michael A NicholsSteven J Chmura
Jul 17, 2009·Critical Reviews in Oncology/hematology·Martin Pinquart, Paul R Duberstein
Jun 3, 2008·Seminars in Radiation Oncology·Michael L Steinberg
Jul 8, 2003·International Journal of Cancer. Journal International Du Cancer·Naomal M A Perera, Gerald P H Gui
Aug 24, 2006·Psycho-oncology·Kenneth P TercyakChristopher A Loffredo
Jan 12, 2008·American Journal of Hematology·Pramvir S VermaBrendan M Weiss
Feb 12, 2014·Journal of the American Geriatrics Society·Gretchen KimmickUNKNOWN Centers for Disease Control and Prevention National Program of Cancer Registry Patterns of Care Study Group
Oct 13, 2015·Journal of the American Geriatrics Society·Himani AggarwalPatrick J Loehrer
Sep 28, 2015·Breast Cancer Research and Treatment·Alicia Padron-MonederoMargaret M Byrne
Nov 26, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Abdurahman KuzhanHakan Buyukhatipoglu
Mar 1, 2015·Breast Cancer Research and Treatment·Alicia Padron-MonederoMargaret M Byrne
Jun 12, 2002·Oncology Nursing Forum·Noreen M Aziz, Julia H Rowland
Jan 7, 2010·Breast Cancer Research and Treatment·Emanuela TaioliCamille Ragin
Aug 29, 2016·Breast Cancer Research and Treatment·Raquel A NunesSandra M Swain
Sep 2, 1999·Journal of the National Cancer Institute·M U YoodS R Wolman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.